2026-04-15 • stocktitan.net
Actuate Therapeutics Announces Nature Medicine Report Highlighting Clinical Trial Data Demonstrating a Twofold Increase in Survival Rates Using Elraglusib and Chemotherapy for Previously Untreated Metastatic Pancreatic Ductal Aden